Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marlid Cruz-Ramos

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|November 13, 2019
CAR-T cell and Personalized MedicineMarlid Cruz-Ramos, Jesús García-Foncillas
Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022
An overview of resistance to chemotherapy in osteosarcoma and future perspectivesDorian Yarih Garcia-Ortega, Sara Aileen Cabrera-Nieto, Haydee Sarai Caro-Sánchez, et al.
International Journal of Molecular Sciences|November 27, 2024
The Role of Adenosine in Overcoming Resistance in SarcomasMarlid Cruz-Ramos, Sara Aileen Cabrera-Nieto, Mario Murguia-Perez, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|August 16, 2024
Phase angle as a potential tool to evaluate chronic inflammatory state and predict quality of life deterioration in women with breast cancer and obesity: A narrative reviewFernanda Sarahí Fajardo-Espinoza, Sara Aileen Cabrera-Nieto, Ana Lorena Espada-Vargas, et al.
Journal of Cancer Research and Clinical Oncology|April 26, 2020
Afatinib is active in osteosarcoma in osteosarcoma cell linesMarlid Cruz-Ramos, Yessica Zamudio-Cuevas, Daniel Medina-Luna, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 8, 2020
Communication Challenges Among Oncologists in MexicoAlejandra Platas, Marlid Cruz-Ramos, Fernanda Mesa-Chavez, et al.
Journal of Cancer Research and Clinical Oncology|August 20, 2020
Correction to: Afatinib is active in osteosarcoma cell linesMarlid Cruz-Ramos, Yessica Zamudio-Cuevas, Daniel Medina-Luna, et al.
Journal of Geriatric Oncology|October 18, 2018
Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancerMarlid Cruz-Ramos, Laura Del Puerto-Nevado, Binbin Zheng, et al.
Frontiers in Immunology|November 16, 2020
NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19Alberto López-Reyes, Carlos Martinez-Armenta, Rocio Espinosa-Velázquez, et al.
Neuroendocrinology|January 29, 2020
Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine CarcinomasMaría Rodríguez-Remírez, Laura Del Puerto-Nevado, María Jesús Fernández-Aceñero, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|November 13, 2019
CAR-T cell and Personalized MedicineMarlid Cruz-Ramos, Jesús García-Foncillas
Cancer Drug Resistance (Alhambra, Calif.)|September 30, 2022
An overview of resistance to chemotherapy in osteosarcoma and future perspectivesDorian Yarih Garcia-Ortega, Sara Aileen Cabrera-Nieto, Haydee Sarai Caro-Sánchez, et al.
International Journal of Molecular Sciences|November 27, 2024
The Role of Adenosine in Overcoming Resistance in SarcomasMarlid Cruz-Ramos, Sara Aileen Cabrera-Nieto, Mario Murguia-Perez, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|August 16, 2024
Phase angle as a potential tool to evaluate chronic inflammatory state and predict quality of life deterioration in women with breast cancer and obesity: A narrative reviewFernanda Sarahí Fajardo-Espinoza, Sara Aileen Cabrera-Nieto, Ana Lorena Espada-Vargas, et al.
Journal of Cancer Research and Clinical Oncology|April 26, 2020
Afatinib is active in osteosarcoma in osteosarcoma cell linesMarlid Cruz-Ramos, Yessica Zamudio-Cuevas, Daniel Medina-Luna, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 8, 2020
Communication Challenges Among Oncologists in MexicoAlejandra Platas, Marlid Cruz-Ramos, Fernanda Mesa-Chavez, et al.
Journal of Cancer Research and Clinical Oncology|August 20, 2020
Correction to: Afatinib is active in osteosarcoma cell linesMarlid Cruz-Ramos, Yessica Zamudio-Cuevas, Daniel Medina-Luna, et al.
Journal of Geriatric Oncology|October 18, 2018
Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancerMarlid Cruz-Ramos, Laura Del Puerto-Nevado, Binbin Zheng, et al.
Frontiers in Immunology|November 16, 2020
NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19Alberto López-Reyes, Carlos Martinez-Armenta, Rocio Espinosa-Velázquez, et al.
Neuroendocrinology|January 29, 2020
Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine CarcinomasMaría Rodríguez-Remírez, Laura Del Puerto-Nevado, María Jesús Fernández-Aceñero, et al.
Pageof 3